In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Are high power electric vehicle chargers safe for patients with cardiac devices?

Device Therapy
Implantable Cardioverter-Defibrillator (ICD)

Barcelona, Spain – 17 April 2023:  High power electric vehicle chargers are safe for patients with pacemakers and defibrillators, according to a study published today in EP Europace,1 a journal of the European Society of Cardiology (ESC) and presented at EHRA 2023,2 a scientific congress of the ESC.

“The new high power charging stations for electric cars have the potential to create strong electromagnetic fields and cause electromagnetic interference in pacemakers and defibrillators, leading them to malfunction,” said study author Dr. Carsten Lennerz of the German Heart Centre Munich. “We previously investigated the risk of electromagnetic interference with cardiac devices while driving electric cars and found that the largest electromagnetic field was located along the charging cable.3 This was the first study to examine the risk of electromagnetic interference in patients with cardiac implantable electronic devices (CIEDs) while using high power chargers.”

Pacemakers and defibrillators are used to treat patients with heart rhythm disorders or heart failure. It is estimated that 1 to 1.4 million pacemakers will be implanted globally in 2023.4,5 Given that the average life expectancy with a pacemaker is 8.5 years, the number of people with a pacemaker worldwide is likely to be in the region of 8 to 12 million.6 In addition, approximately 150,000 to 200,000 patients across the world receive an implantable cardioverter defibrillator (ICD) each year.7 

High power chargers delivering up to 350 kW were developed to shorten charging time. The new chargers use DC (direct current) which allows for higher power delivery, while older or home chargers use AC (alternating current). With a greater charging current there may be a stronger magnetic field and a higher risk of electromagnetic interference which could cause a pacemaker to stop pacing or a defibrillator to deliver painful shock therapy inappropriately (due to falsely detecting a rapid arrhythmia). There are no official recommendations on the use of high power chargers for patients with CIEDs.

The study included 130 patients with a pacemaker or defibrillator. The average age was 59 years and 21% were women. Four publicly available, fully electric cars capable of high power charging were used during the study.8 However, these cars cannot take the maximal charge of 350 kW. Since it is highly likely that future electric cars will take the highest charge, the researchers also used a test vehicle which could draw 350 kW from the high power chargers.9

Participants had their cardiac devices programmed to optimise detection of electromagnetic interference. They were then asked to plug in and charge each car with the charging cable placed directly over their cardiac device to maximise the likelihood of electromagnetic interference. Patients were monitored for any malfunction of their cardiac device such as a failure to deliver pacing therapy or inappropriately sensing abnormally fast heart rhythms. The cardiac devices were also checked for any change in their programming or damage after charging the cars.

In total, 561 charges were performed during which the researchers did not observe any adverse events caused by electromagnetic interference. Specifically, there was no inhibition of pacing in pacemakers nor inappropriate detection of rapid arrhythmias that might lead to painful shock therapy for patients with defibrillators.

Dr. Lennerz said: “This study was designed as a worst-case scenario to maximise the chance of electromagnetic interference. Despite this, we found no clinically relevant electromagnetic interference and no device malfunction during the use of high power chargers, suggesting that no restrictions should be placed on their use for patients with cardiac devices.”

He noted that the study focused on high power charging technology rather than home chargers. “Home chargers use a smaller current but AC generates a different magnetic field than DC,” he said. “Home charging is likely safe with sensible precautions, such as not staying next to the charging cable for extended periods of time.”

Dr. Lennerz concluded: “Patients with cardiac devices can be reassured that charging electric cars with high power chargers is safe. The risk of malfunction of pacemakers and defibrillators is extremely low in this situation. Sitting inside the car or standing next to the charging cable or charger is also safe. However, we would recommend not placing the charging cable directly over the cardiac device to maintain distance from the charging elements.”



1Lennerz C, Schaarschmidt C, Blazek P, et al. High-power chargers for electric vehicles: Are they safe for patients with pacemakers and defibrillators? Europace. 2023. doi:10.1093/europace/euad042. 
Link will go live on publication: abstract ‘Electric cars and high power chargers: Are they safe for patients with cardiac implantable electronic devices?’ will be presented during the session ‘Device Therapy - ICD’ which takes place on 17 April at 15:40 CEST at Moderated ePosters 3.
3Lennerz C, Horlbeck L, Weigand S, et al. Patients with pacemakers or defibrillators do not need to worry about e-Cars: An observational study. Technol Health Care. 2020;28:1–12.
4Global number of pacemakers in 2016 and a forecast for 2023 (in million units):
5Sichrovsky T, Mittal S. I need a pacemaker-what are my options? JAMA Cardiol. 2020;5:1456.
6Brunner M, Olschewski M, Geibel A, et al. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J. 2004;25:88–95.
7Koneru JN, Jones PW, Hammill EF, et al. Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads. J Am Heart Assoc. 2018;7:e007691.
8The four electric cars used were the Porsche Taycan Turbo, Volkswagen ID.3 Pro Performance, Tesla Model 3 Performance and Audi e-tron 55 quattro.
9An IONITY test device was used.


Notes to editor

Authors: ESC Press Office 
Tel: +33 (0)489 872 075
Follow us on Twitter @ESCardioNews 

Funding: The electric cars and charging towers were loaned to the study group for the duration of the study. IONITY provided a high power simulation device and use of charging infrastructure at their test site. The study was supported by the German Foundation of Heart Research. The German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung) performed the measurement of the electromagnetic fields.

Disclosures: None of the authors have any conflict of interest to report.

About the European Heart Rhythm Association

The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve patients’ quality of life and reduce sudden cardiac death by limiting the impact of heart rhythm disturbances. 

About the EHRA Congress     #EHRA2023
EHRA 2023 is the annual congress of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).

About the European Society of Cardiology 

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Information for journalists about registration for EHRA 2023
EHRA 2023 will be held 16 to 18 April at the Fira Gran Via, Hall 8, in Barcelona, Spain and online. Explore the scientific programme.

  • Free registration applies to accredited press.
  • Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy.
  • The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
  • The ESC Press Office decision is final regarding all press registration requests.